Sireen AG

Acquisitions Xenova sells assets to Bioventix Bioventix Ltd. (Cambridge, UK) Xenova Group PLC (Slough, Berkshire, UK) For £800k ($1.5mm) in cash, oncology and addiction therapeutics company Xenova G

Discovery risk is for VCs like yesterday's newspaper. With the Big Pharma market for discovery tools abysmally quiet, early-stage funding for such firms saw a steep decline. Bioinformatics, for exampl

Times are hard all over, as a tally of 2002 health care financings makes plain: as of late November, just 353 private financings had been finalized across all sectors—biotechnology and pharmaceuticals